Menu

Gene Drives and Other Controversies

Aedes and Anopheles control; three-parent babies; the PhD glut

Jan 1, 2017
Mary Beth Aberlin

ANDRZEJ KRAUZEAt the end of October 2015, alarm bells began ringing: hundreds of pregnant women in northeastern Brazil were giving birth to babies with unusually small heads and an unusual pattern of very severe neurological damage. Epidemiologists observed an association of the condition with the mothers’ infection by a mosquito-borne virus called Zika early in pregnancy, and researchers raced to demonstrate a causal relationship. The virus generated such buzz (and fear) that reports were omnipresent throughout 2016, both in the popular media and in the scientific literature. At one point, officials considered canceling the 2016 Olympic Games, which were eventually held in Rio de Janeiro in August with no cases of infection reported.

Last February, as infections continued to mount across Latin America and the Caribbean, the World Health Organization (WHO) declared Zika a “public health emergency of international concern.” After visitors to countries in those regions returned home with infections, researchers confirmed that the virus could be transmitted sexually and was associated with an increased incidence of peripheral nerve damage manifested as muscle weakness and paralysis (Guillain-Barré syndrome). Then, in July, Zika-harboring mosquitoes appeared in the continental United States, with 184 locally acquired cases reported in Florida (at press time. As of 12/28 the number has risen to 210). Vigilant monitoring and heavy insecticide spraying seems to have halted active transmission there, but at the end of November, Texas became the second state to report a locally acquired case of Zika (6 as of 12/28). A week earlier, on November 18, as infections had begun to wane both in the Southern Hemisphere and in the U.S., WHO changed Zika’s classification from international emergency to one of “significant enduring public health challenge.” Despite this status change, however, Zika—both the virus and the illness—still harbors many baffling mysteries and research continues at a furious pace.

As the epidemic evolved, life scientists reached across disciplines to immediately and openly share results that could shed light on why the virus can be so damaging and how its spread might be controlled. To search for clues on how to rein in the virus, the Zika genome was sequenced in short order, and mosquito researchers formed the Aedes Genome Working Group, which rushed to assemble a more-complete map of the DNA sequence of A. aegypti, a mosquito that transmits not only the Zika virus but also dengue and chikungunya.

While Zika hogged the headlines in 2016, a mosquito of another genus, Anopheles, continues to play its ages-old role as carrier of the parasite responsible for a scourge suffered by millions upon millions—malaria. Because no vaccine exists yet, researchers are investigating improved methods to manage the parasite’s spread by tinkering with the mosquito itself. In this issue’s cover story, Tony Nolan and Andrea Crisanti write about how knowledge of the mosquito genes responsible for key behaviors can inform the design of gene drives—the insertion of genetic elements into the insect’s DNA that are selectively inherited and could result in a radical diminution of mosquito populations. But while gene drives “are species-specific, self-sustaining, and have the potential to be long-term and cost-effective,” the authors write, “the deci­sion to deploy a gene drive technology does not, and should not, lie with the sci­entists who design it.”

Even though the value of a gene drive that wipes out the insect carrier of a disease that affects millions is obvious, implementation of such methods remains highly controversial, and a careful appraisal of the approach’s ethical and ecological implications is imperative.

Other articles about controversial issues can be found in “Ethical Considerations of Three-Parent Babies,” which lays out the ethical issues surrounding mitochondrial replacement therapy, and suggestions about how to deal with the glut of life science PhDs (“Addressing Biomedical Science's PhD Problem”).

Scientific research is no stranger to controversy. And when we dig it up, you can be sure we will share it with you. 

Mary Beth Aberlin  Editor-in-Chief
 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.